Please join Connecticut companies that are working on COVID-19 for a panel discussion on the current state of therapeutic and vaccine pipelines, new developments, and future plans.
Moderator:
Mostafa Analoui, PhD, Executive Director of Venture Development, Office of the Vice President for Research & Technology Incubation Program (TIP), UConn
Panelists:
Mark Adams, PhD, Professor & Director, General Manager Microbial Genomic Services, The Jackson Laboratory
Bijan Almassian, PhD, President & CEO, CaroGen
Anil Diwan, PhD, Executive Chairman & President, NanoViricides
Gary Mathias, Co-Founder & CEO, Thetis Pharmaceuticals
Please note, capacity is limited and registration is on a first come, first serve basis. If you are not able to attend the live event, a recording will be made available.
Presented by:
Hosted by: